Brainstorm Cell Therapeutics CEO Anthony S. Fiorino purchased 18,000 shares of the stock in a transaction that occurred on Monday, September 15th. The shares were purchased at an average price of $0.28 per share, with a total value of $5,040.00.
http://ift.tt/1r2iWN0
http://ift.tt/1r2iWN0
No comments:
Post a Comment